Position statement of the EADV Melanoma Task Force on recommendations for the management of cutaneous melanoma patients during COVID-19

J Eur Acad Dermatol Venereol. 2021 Jul;35(7):e427-e428. doi: 10.1111/jdv.17252. Epub 2021 Apr 13.

M Arenbergerova¹, A Lallas², E Nagore^{3

4}, L Rudnicka⁵, A M Forsea^{6

7}, M Pasek¹, F Meier^{8

9}, K Peris^{10

11}, J Olah¹², C Posch^{13

14}

¹ Department of Dermatovenereology, Third Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech Republic.
² First Department of Dermatology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.
³ Department of Dermatology, Instituto Valenciano de Oncología, Valencia, Spain.
⁴ School of Medicine, Universidad Católica de Valencia San Vicente Mártir, Valencia, Spain.
⁵ Department of Dermatology, Medical University of Warsaw, Warsaw, Poland.
⁶ Carol Davila University of Medicine and Pharmacy Bucharest, Bucharest, Romania.
⁷ Oncologic Dermatology Department, Elias University Hospital Bucharest, Bucharest, Romania.
⁸ Skin Cancer Center at the University Cancer Centre Dresden and National Center for Tumor Diseases, Dresden, Germany.
⁹ Department of Dermatology, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany.
¹⁰ UOC di Dermatologia, Università Cattolica del Sacro Cuore, Rome, Italy.
¹¹ Dermatologia Fondazione Policlinico Universitario A. Gemelli - IRCCS, Rome, Italy.
¹² Department of Oncotherapy, Department of Dermatology and Allergology, University of Szeged, Szeged, Hungary.
¹³ Department of Dermatology and Allergy, School of Medicine, German Cancer Consortium (DKTK), Technical University of Munich, Munich, Germany.
¹⁴ Faculty of Medicine, Sigmund Freud University Vienna, Vienna, Austria.

No abstract available

Publication types